Диссертация (1139940), страница 21
Текст из файла (страница 21)
// JACC Cardiovasc Imaging, 2012, 5, No. 4, P. 422-9.100. Fuchs M., Briel M., Daikeler T., Walker U., Rasch H., Berq S., et al. Theimpact of 18F-FDG PET on the management of patients with suspected large vesselvasculitis. // Eur J Nuc Med Mol Imaging, 2012, 39, No. 2, P. 344-53.101. Karapolat I., Kalfa M., Keser G., Yalcin M., Inal V., Kumanlioqlu T., etall. Comparison of F18-FDG PET/CT findings with current clinical disease status inpatients with Takayasu’s arteritis. // Clin Exp Rheumatol, 2013, 31, No. 1, P.
15-21.102. Unger M., Karanikas G., Kerschbaumer A., Winkler S., Aletaha D. Feverof unknown origin (FUO) revised. // Wien Klin Wochenschr, 2016, 128, No. 21-22,P. 796–801.103. Czihal M., Tatò F., Förster S., Rademacher A., Schulze-Koops H.,Hoffmann U.
Fever of unknown origin as initial manifestation of large vessel giant137cell arteritis: diagnosis by colour-coded sonography and 18-FDG-PET. // Clin ExpRheumatol, 2010, 28, No. 4, No. 549-52.104. Lariviere D., Benali K., Coustet B., Pasi N., Hyafil F., Klein I., et all.Positron emission tomography and computed tomography angiography for thediagnosis of giant cell arteritis: A real-life prospective study. // Medicine(Baltimore), 2016, 95, No. 30, e4146.105. Evans J., Hunder G. Polymyalgia rheumatica and giant cell arteritis. //Rheum Dis Clin North Am, 2000, 26, No.
3, P. 493-515.106. Balink H., Houtman P., Collins J. 18F-FDG PET versus PET/CT as adiagnostic procedure for clinical suspicion of large vessel vasculitis. // Clin Rheum,2011, 30, No. 8, P. 1139–1141.107. Oh M., Kim J., Shin K., Park S., Ryu J., Kim J., et all. Imagingatherosclerosis in the carotid arteries with F-18-Fluoro-2-deoxy-D-glucose positronemission tomography: effect of imaging time after injection on guantitativemeasurement. // Nucl Med Mol Imaging, 2010, 44, No. 4, P. 261-6.108.
Ponte C., Rodrigues A., O’Neill L., Luqmani R. Giant cell arteritis:Current treatment and management. // World J Clin Cases, 2015, 3, No. 6, P. 484–494.109. Serafim A., Singh S., Piper J., Hutchings A., Bradburn M., Ponte C., etall. Early Halo Sign Features on Ultrasound Examination of Treated Patients withGiant Cell Arteritis. // Arthritis Rheumatol, 2014, 66, P. 349.110. Sait S., Sabire Y., Meftune Ö., Metin H., Nurhan E., Hediye Ç.
F-18FDG PET/CT findings of a patient with Takayasu arteritis before and after therapy.// Mol Imag Radionuc Ther, 2012, 21, No. 1, P. 32–34.111. Stellingwerff M., Brouwer E., Lensen K., Rutgers A., Arends S., Geest K.,et al. Different scoring methods of FDG PET/CT in giant cell arteritis. / Medicine,2015, 94, No.37, P. 1542-9.138112. Liozon E., Monteil J., Ly K., Vidal E. Vasculitis assessment with [18F]FDG positron emission tomography. // Rev Med Interne, 2010, 31, No. 6, P.
417-27.113. Glaudemans A., de Vries E., Galli F., Dierckx R., Slart R., Signore A.The use of 18F-FDG-PET/CT for diagnosis and treatment monitoring ofinflammatory and infectious diseases. // Clin Dev Immuno, 2013, Article ID623036, P. 14.114. Otomi Y., Otsuka H., Terazawa K. Nose H., Kubo M., Yoneda K., et all.(18)F-2-fluoro-2-deoxyglucose uptake in or adjacent to blood vessel walls. //J MedInvest, 2013, 60, No. 1-2, P. 15-20.115. Afzelius P., Nielsen O., Alstrup F., Bender D., Leifsson P., Jensen S., etall. Biodistribution of the radionuclides 18F-FDG, 11C-methionine, 11C-PK11195,and 68Ga-citrate in domestic juvenile female pigs and morphological and molecularimaging of the tracers in hematogenously disseminated Staphylococcus aureuslesion.
// Am J Nucl Med Mol Imaging, 2016, 6, No. 1, P. 42–58.116. Gotthardt M., Bleeker-Rovers C.P., Boerman O.C., Oyen W.J. Imagingof inflammation by PET, conventional scintigrsphy, and other imaging techniques. //J Nucl Med, 2010, 51, No. 12, P. 1937-49.117. Ninan J.V., Lester S., Hill C.. Giant cell arteritis – beyond temporalartery biopsy and steroid.
// Intern Med, 2017, 9, doi:10.1111/imj.13483..
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
